News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
258,901 Results
Type
Article (13486)
Company Profile (103)
Press Release (245312)
Section
Business (87838)
Career Advice (460)
Deals (15316)
Drug Delivery (60)
Drug Development (36466)
Employer Resources (49)
FDA (6233)
Job Trends (6179)
News (149749)
Policy (13992)
Tag
Academia (435)
Africa (312)
Alliances (23038)
Alzheimer's disease (322)
Approvals (6214)
Arizona (35)
Artificial intelligence (39)
Asia (19635)
Australia (2531)
Bankruptcy (143)
Best Places to Work (4198)
Biosimilars (31)
Biotechnology (41)
C2C Services and Suppliers (10606)
California (587)
Canada (432)
Cancer (125)
Career advice (402)
Cell therapy (23)
China (64)
Clinical research (30033)
Collaboration (51)
Compensation (23)
Connecticut (24)
COVID-19 (737)
Cystic fibrosis (21)
Data (83)
Diabetes (25)
Diagnostics (1200)
Drug pricing (47)
Earnings (31140)
Employer resources (43)
Europe (38382)
Events (36255)
Executive appointments (79)
FDA (6297)
Florida (73)
Funding (37)
Gene therapy (40)
GLP-1 (259)
Government (1249)
Healthcare (3504)
Hotbed/Location (177935)
Illinois (67)
Indiana (59)
Infectious disease (741)
Inflammatory bowel disease (40)
Interviews (57)
IPO (5781)
IRA (22)
Job creations (2046)
Job search strategy (371)
Kansas (49)
Layoffs (164)
Legal (3398)
Lung cancer (27)
Manufacturing (45)
Maryland (87)
Massachusetts (515)
Medical device (1251)
Medtech (1253)
Mergers & acquisitions (9472)
Metabolic disorders (99)
Minnesota (37)
Neuroscience (371)
New Jersey (241)
New York (164)
NextGen Class of 2024 (1576)
Non-profit (588)
North Carolina (221)
Northern California (261)
Obesity (60)
Ohio (29)
Opinion (106)
Patents (39)
Pennsylvania (185)
People (28231)
Pharmaceutical (59)
Phase I (7819)
Phase II (12696)
Phase III (11405)
Pipeline (48)
Podcasts (35)
Policy (36)
Postmarket research (1398)
Preclinical (3127)
Press Release (25)
Rare diseases (50)
Real estate (2624)
Regulatory (9688)
Research institute (561)
Resumes & cover letters (55)
South America (496)
Southern California (263)
Startups (1624)
Texas (75)
United States (2601)
Vaccines (89)
Washington State (46)
Weight loss (52)
Date
Today (28)
Last 7 days (217)
Last 30 days (760)
Last 365 days (13309)
2024 (9232)
2023 (14245)
2022 (19558)
2021 (20072)
2020 (19038)
2019 (14888)
2018 (11715)
2017 (13892)
2016 (13130)
2015 (15474)
2014 (12419)
2013 (10596)
2012 (11395)
2011 (11922)
2010 (10888)
258,901 Results for "ironwood pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Ironwood Pharmaceuticals Reports First Quarter 2024 Results
Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, reported its first quarter 2024 results and recent business performance.
May 9, 2024
·
34 min read
Genetown
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:00 a.m. ET at the Marriott Marquis in New York City.
May 30, 2024
·
2 min read
Genetown
Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that management will participate in a fireside chat at The Citizens JMP Life Sciences Conference on Monday, May 13, 2024 at 10:00 a.m. ET at the New York Hilton Midtown.
May 6, 2024
·
2 min read
Business
Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
Ironwood Pharmaceuticals, Inc. announced it will host its first quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, May 9, 2024.
April 25, 2024
·
2 min read
Genetown
Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024
Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week ® 2024.
May 1, 2024
·
12 min read
Business
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, reported its fourth quarter and full year 2023 results and recent business performance.
February 15, 2024
·
37 min read
Business
Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance
Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, announced financial guidance for full year 2024.
January 8, 2024
·
13 min read
Drug Development
Ironwood Nabs Phase III Win, Still Sees Stock Nosedive
Despite Ironwood Pharmaceuticals’ apraglutide getting positive late-stage study results in treating short bowel syndrome with intestinal failure, the stock plummeted nearly 40% on Thursday.
March 1, 2024
·
2 min read
·
Tyler Patchen
Business
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update Call
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its fourth quarter and full year 2023 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, February 15, 2024.
February 1, 2024
·
2 min read
Genetown
Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) announced today that the company will present findings from four studies evaluating apraglutide in adults with short bowel syndrome with intestinal failure (SBS-IF), a condition in which they are dependent on parenteral support, during the American Society for Parenteral and Enteral Nutrition (ASPEN) 2024 Nutrition Science & Practice Conference.
February 23, 2024
·
8 min read
1 of 25,891
Next
